Showing results (1921-1930 of 2,286) with videos related to
Sort By:
Pageof 229
Human Molecular Genetics|March 21, 1998
Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genesP Vehmanen, L S Friedman, H Eerola, et al.Journal of Neuro-Oncology|April 27, 2012
Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective seriesEmil Lou, Ashley L Sumrall, Scott Turner, et al.Gut Microbes|June 6, 2022
Dietary fiber-based regulation of bile salt hydrolase activity in the gut microbiota and its relevance to human diseaseArthur Kastl, Wenjing Zong, Victoria M Gershuni, et al.The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|July 17, 2021
A Scoping Review of Adolescent Health IndicatorsHolly Newby, Andrew D Marsh, Ann-Beth Moller, et al.The British Journal of Ophthalmology|March 14, 2025
Comparison of structure-function correlation among IMO visual function analyser and Humphrey field analyserJoyce Kang, Rafaella Nascimento E Silva, Julia Anne Kim, et al.Ophthalmology|May 20, 2008
Screening for narrow angles in the singapore population: evaluation of new noncontact screening methodsRaghavan Lavanya, Paul J Foster, Lisandro M Sakata, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 24, 2019
Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting (CINV) in glioma patients receiving adjuvant temozolomideMallika P Patel, Sarah Woodring, Dina M Randazzo, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 18, 2018
Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative ColitisStephen Hanauer, Remo Panaccione, Silvio Danese, et al.Molecular Cancer Therapeutics|September 16, 2004
Brain tumor cell lines resistant to O6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have O6-alkylguanine-DNA alkyltransferase mutationsManny D Bacolod, Stewart P Johnson, Anthony E Pegg, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 16, 2014
Antigen recognition in the islets changes with progression of autoimmune islet infiltrationRobin S Lindsay, Kaitlin Corbin, Ashley Mahne, et al.Pageof 229